Venetoclax and azacitidine for molecular relapse after intensive chemotherapy in NPM1 or CBF AML: a FILO study by Jules Higué, Corentin Orvain, Pierre-Yves Dumas, Pierre Peterlin, Marie-Anne Hospital, Sabrina Barrière, Audrey Couturier, Martin Carre, Areti Chantzi, Emmanuelle Tavernier, Éric Delabesse, Audrey Bidet, Anne Bouvier, Marie-Joelle Mozziconacci, Lauren Véronèse, Cédric Pastoret, Sylvie Tondeur, Pascale Flandrin-Gresta, Sébastien Lachot, Marine Cazaux, Sylvain Thépot, Edouard Forcade, Patrice Chevallier, Raynier Devillier, Gaspar Aspas Requena, Sarah Bertoli, Arnaud Pigneux, Christian Récher

Get full text